|
Volumn 28, Issue 5, 2013, Pages 625-632
|
Pilocytic astrocytoma: a disease with evolving molecular heterogeneity.
a a
a
not available
*
|
Author keywords
[No Author keywords available]
|
Indexed keywords
B RAF KINASE;
BRAF PROTEIN, HUMAN;
KRAS PROTEIN, HUMAN;
MITOGEN ACTIVATED PROTEIN KINASE;
ONCOPROTEIN;
RAS PROTEIN;
ASTROCYTOMA;
BRAIN TUMOR;
CELL TRANSFORMATION;
CEREBELLUM TUMOR;
CHILD;
CHROMOSOME ABERRATION;
GENETIC HETEROGENEITY;
GENETICS;
HUMAN;
HYPOTHALAMUS TUMOR;
MOLECULARLY TARGETED THERAPY;
OPTIC CHIASM;
OPTIC NERVE TUMOR;
POINT MUTATION;
PROGNOSIS;
REVIEW;
TRANSCRIPTION INITIATION;
TUMOR SUPPRESSOR GENE;
ASTROCYTOMA;
BRAIN NEOPLASMS;
CELL TRANSFORMATION, NEOPLASTIC;
CEREBELLAR NEOPLASMS;
CHILD;
CHROMOSOME ABERRATIONS;
EXTRACELLULAR SIGNAL-REGULATED MAP KINASES;
GENES, NEUROFIBROMATOSIS 1;
GENETIC HETEROGENEITY;
HUMANS;
HYPOTHALAMIC NEOPLASMS;
MOLECULAR TARGETED THERAPY;
OPTIC CHIASM;
OPTIC NERVE NEOPLASMS;
POINT MUTATION;
PROGNOSIS;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS B-RAF;
RAS PROTEINS;
TRANSCRIPTIONAL ACTIVATION;
|
EID: 84885097535
PISSN: None
EISSN: 17088283
Source Type: None
DOI: 10.1177/0883073813476141 Document Type: Review |
Times cited : (46)
|
References (0)
|